The use of continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) systems has gained wide acceptance in diabetes care. These devices have been demonstrated to be clinically valuable, improving glycemic control and reducing risks of hypoglycemia in ambulatory patients...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!